Literature DB >> 26766983

Squamous cell carcinoma of the lung with simultaneous metastases to peritoneum and skeletal muscle.

Sung Heon Song1, Yoon Jung Oh1, Young Nam Kim1, Ha Hun Song2, Chang Won Ha3.   

Abstract

Skeletal muscle and peritoneum are rare sites of metastases from lung cancer. We report a case of squamous cell lung cancer with concurrent metastases to skeletal muscle and peritoneum. A 71-year-old man was diagnosed with squamous cell carcinoma of the right lower lobe with metastasis to the right hilar lymph node at clinical stage T3N1M0. Because of poor performance status and comorbidity, he only received radiation therapy. Positron emission tomography-computed tomography for mid-assessment of response showed two abnormal hypermetabolic lesions in the peritoneum of the left upper quadrant area and the left thigh muscle. We performed a needle-approach biopsy in each lesion and found both of the lesions were metastases from lung cancer. The patient died after two months.

Entities:  

Keywords:  Metastasis; peritoneum; skeletal muscle; squamous cell carcinoma of lung

Year:  2014        PMID: 26766983      PMCID: PMC4704279          DOI: 10.1111/1759-7714.12034

Source DB:  PubMed          Journal:  Thorac Cancer        ISSN: 1759-7706            Impact factor:   3.500


  6 in total

1.  Distribution of distant metastases from newly diagnosed non-small cell lung cancer.

Authors:  L E Quint; S Tummala; L J Brisson; I R Francis; A S Krupnick; E A Kazerooni; M D Iannettoni; R I Whyte; M B Orringer
Journal:  Ann Thorac Surg       Date:  1996-07       Impact factor: 4.330

2.  Forearm muscle metastasis as an initial clinical manifestation of lung cancer.

Authors:  Kyoichi Kaira; Tamotsu Ishizuka; Noriko Yanagitani; Noriaki Sunaga; Takafumi Tsuchiya; Takeshi Hisada; Masatomo Mori
Journal:  South Med J       Date:  2009-01       Impact factor: 0.954

3.  Peritoneal carcinomatosis in lung cancer patients.

Authors:  H Satoh; H Ishikawa; Y T Yamashita; K Kurishima; M Ohtsuka; K Sekizawa
Journal:  Oncol Rep       Date:  2001 Nov-Dec       Impact factor: 3.906

4.  Age and comorbidity as independent prognostic factors in the treatment of non small-cell lung cancer: a review of National Cancer Institute of Canada Clinical Trials Group trials.

Authors:  Timothy R Asmis; Keyue Ding; Lesley Seymour; Frances A Shepherd; Natasha B Leighl; Tim L Winton; Marlo Whitehead; Johanna N Spaans; Barbara C Graham; Glenwood D Goss
Journal:  J Clin Oncol       Date:  2008-01-01       Impact factor: 44.544

5.  General practitioner assessment of stage and performance status in lung cancer patients at a population level: implications for prognosis and radiotherapy needs analyses.

Authors:  S Tyldesley; T W Roques; S Erridge
Journal:  Lung Cancer       Date:  2007-05-07       Impact factor: 5.705

6.  Skeletal muscle metastasis from non-small cell lung cancer.

Authors:  Daniel Pop; Ahmad S Nadeemy; Nicolas Venissac; Patrice Guiraudet; Josiane Otto; Michel Poudenx; Jérôme Mouroux
Journal:  J Thorac Oncol       Date:  2009-10       Impact factor: 15.609

  6 in total
  4 in total

1.  An unusual case of isolated peritoneal metastases from lung adenocarcinoma.

Authors:  Aziz Bazine; Mohamed Fetohi; Med Reda Khmamouch; Tarik Namad; Mohamed Ichou; Hassan Errihani
Journal:  Case Rep Oncol       Date:  2014-08-22

2.  Peritoneum as the sole distant metastatic site of lung adenosquamous cell carcinoma: a case report.

Authors:  Pan Yang; Wei-Liang Li; Jeff-X Zhou; Yu-Bo Yang; Xia-Xiang Jin
Journal:  J Med Case Rep       Date:  2017-09-27

3.  Upfront Skeletal Muscle Metastases from Non-small Cell Lung Carcinoma: Report of an Extremely Rare Occurrence Detected by 18F-Fluorodeoxyglucose Positron Emission Computed Tomography Scan.

Authors:  Abhishek Purkayastha; Sankalp Singh; Niharika Bisht; Prabha Shankar Mishra; Azhar Husain
Journal:  Indian J Nucl Med       Date:  2018 Oct-Dec

4.  Skeletal muscle metastasis from squamous cell lung cancer was first found by ultrasound: a case report.

Authors:  Lin Du; Ying Sun
Journal:  Transl Cancer Res       Date:  2019-12       Impact factor: 1.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.